NIH Locks Doors for Secret Genome Grant Discussions
Published Date: 4/1/2025
Notice
Summary
The National Human Genome Research Institute is holding a private virtual meeting on May 9, 2025, to review grant applications related to inherited disease research. This meeting is closed to protect sensitive information like trade secrets and personal details. Researchers applying for grants should note this important step in the funding process, which helps decide who gets money for their projects.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed grant review meeting for researchers
If you are a researcher applying for inherited disease research grants, the Center for Inherited Disease Research Access Committee will hold a closed virtual meeting on May 9, 2025 from 11:30 a.m. to 12:30 p.m. to review and evaluate grant applications. The meeting is closed to protect confidential trade secrets, patentable material, and personal information, and it is a formal step that helps decide who receives grant funding.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-05513 — Glycine From the People's Republic of China: Notice of Preliminary Results of Antidumping Duty Changed Circumstances Review
The U.S. Department of Commerce is checking if Salvi Chemical Industries Limited can join a special program related to duties on glycine from China. This could change how much duty Salvi pays and might affect import rules soon. People involved have a chance to share their thoughts before the final decision.
Next: 2025-05516 — Certain Chocolate Milk Powder and Packaging Thereof; Notice of Institution of Formal Enforcement Proceeding
The U.S. International Trade Commission is starting a formal enforcement action about certain chocolate milk powder and its packaging. This affects companies involved in making or selling these products, especially those linked to orders from late 2022 and 2024. If you’re in the chocolate milk powder business, watch out—this could mean new rules and possible penalties soon!